UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dueling mutations in normal karyotype AML

Blood, 2005-12, Vol.106 (12), p.3681-3682

Gallagher, Robert E.

2005

Volltextzugriff (PDF)

Telomere Length Recovery Strongly Predicts Overall Survival in Acute Promyelocytic Leukemia

Blood, 2014-12, Vol.124 (21), p.2375-2375

2014

Volltextzugriff (PDF)

Design, Synthesis and Biological Evaluation of A Boron Containing Retinoid As a Novel Therapeutic Agent for Acute Promyelocytic Leukemia

Blood, 2011-11, Vol.118 (21), p.5008-5008

2011

Volltextzugriff (PDF)

Alternative splicing of Krüppel-like factor 6 (KLF6) enriched in human androgen-deprived prostate cancer (PC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15191-e15191

2012

Volltextzugriff (PDF)

Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710

Blood, 2011-11, Vol.118 (21), p.258-258

2011

Volltextzugriff (PDF)

Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure

Leukemia, 2006-04, Vol.20 (4), p.556-562

2006

Volltextzugriff (PDF)

Prime-time for real-time Q-RT-PCR in good-prognosis AML?

Blood, 2003-10, Vol.102 (8), p.2709-2710

Gallagher, Robert E.

2003

Volltextzugriff (PDF)

ΔNp73/TAp73 Expression Ratio Is Associated with Poor Outcome in Acute Promyelocytic Leukemia

Blood, 2011-11, Vol.118 (21), p.3536-3536

2011

Volltextzugriff (PDF)

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL)

Blood, 2007-11, Vol.110 (11), p.3167-3167

2007

Volltextzugriff (PDF)

Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy

Blood, 1998-08, Vol.92 (4), p.1172-1183

1998

Volltextzugriff (PDF)

High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial

Blood, 2010-11, Vol.116 (21), p.851-851

2010

Volltextzugriff (PDF)

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All-trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes

Blood, 2007-11, Vol.110 (11), p.2121-2121

2007

Volltextzugriff (PDF)

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Blood, 2000-11, Vol.96 (9), p.3200-3208

2000

Volltextzugriff (PDF)

Common Gene Expression Changes in Matched Pretreatment and Relapse Samples from Eastern Cooperative Oncology Group Acute Promyelocytic Leukemia (APL) Patients Treated on the Chemotherapy (C) or All-Trans Retinoic Acid (ATRA)-Containing (A) Randomization Arms of Protocol E2491

Blood, 2006-11, Vol.108 (11), p.4311-4311

2006

Volltextzugriff (PDF)

Minimizing Therapy for Patients with Acute Promyelocytic Leukemia: Efficacy of Single Cycle of Arsenic-Based Consolidation Therapy

Blood, 2008-11, Vol.112 (11), p.1932-1932

2008

Volltextzugriff (PDF)

Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422

Blood, 2008-11, Vol.112 (11), p.1502-1502

2008

Volltextzugriff (PDF)

Pyrosequencing Analysis of the Methylation Status of the CpG Island in the Retinoic Acid Receptor-β2 (RAR-β2) Gene Promoter

Blood, 2004-11, Vol.104 (11), p.4297-4297

2004

Volltextzugriff (PDF)

Association of PML-RARα fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia : An intergroup molecular study

Blood, 1997-08, Vol.90 (4), p.1656-1663

1997

Volltextzugriff (PDF)

Assessment of Minimal Residual Disease (MRD) by Qualitative RT-PCR (Q-PCR) vs Real-Time Quantitative RT-PCR (RQ-PCR) in a Phase II Study of Acute Promyelocytic Leukemia (APL)

Blood, 2005-11, Vol.106 (11), p.3262-3262

2005

Volltextzugriff (PDF)

Editorial: Arsenic--new life for an old potion

The New England journal of medicine, 1998-11, Vol.339 (19), p.1389

Gallagher, Robert E

1998

Volltextzugriff (PDF)

26 – 50 von 736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(607)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(480)
Life Sciences & Biomedicine
(384)
Humans
(321)
Female
(180)
Male
(160)
Biological And Medical Sciences
(143)
Medical Sciences
(116)
Middle Aged
(99)
Adult
(98)
Aged
(88)
Physical Sciences
(76)
Oncology
(74)
Animals
(68)
Adolescent
(54)
Child
(46)
Hematology
(41)
Risk Factors
(40)
Chemistry
(35)
Treatment Outcome
(34)
Hematologic And Hematopoietic Diseases
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(51)
Cancer Research
(14)
Cheminform
(12)
The Astrophysical Journal
(11)
Nature
(10)
Annals Of Emergency Medicine
(9)
Leukemia Research
(9)
Journal Of The American College Of Cardiology
(8)
Journal Of Virology
(8)
Medicine And Science In Sports And Exercise
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Dueling mutations in normal karyotype AML

Telomere Length Recovery Strongly Predicts Overall Survival in Acute Promyelocytic Leukemia

Design, Synthesis and Biological Evaluation of A Boron Containing Retinoid As a Novel Therapeutic Agent for Acute Promyelocytic Leukemia

Prognostic Impact Of MLL5 transcript Levels On Outcome Of Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Alternative splicing of Krüppel-like factor 6 (KLF6) enriched in human androgen-deprived prostate cancer (PC)

Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710

Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure

Prime-time for real-time Q-RT-PCR in good-prognosis AML?

Aberrant Expression of the MLL5, BAALC, ID1, and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Comparison Between RT-PCR and RQ-PCR for Minimal Residual Disease Detection in Acute Promyelocytic Leukemia: The International Consortium on Acute Promyelocytic Leukemia (IC-APL) Experience

ΔNp73/TAp73 Expression Ratio Is Associated with Poor Outcome in Acute Promyelocytic Leukemia

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL)

Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy

High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All-trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Common Gene Expression Changes in Matched Pretreatment and Relapse Samples from Eastern Cooperative Oncology Group Acute Promyelocytic Leukemia (APL) Patients Treated on the Chemotherapy (C) or All-Trans Retinoic Acid (ATRA)-Containing (A) Randomization Arms of Protocol E2491

Minimizing Therapy for Patients with Acute Promyelocytic Leukemia: Efficacy of Single Cycle of Arsenic-Based Consolidation Therapy

Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422

Pyrosequencing Analysis of the Methylation Status of the CpG Island in the Retinoic Acid Receptor-β2 (RAR-β2) Gene Promoter

Association of PML-RARα fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia : An intergroup molecular study

Assessment of Minimal Residual Disease (MRD) by Qualitative RT-PCR (Q-PCR) vs Real-Time Quantitative RT-PCR (RQ-PCR) in a Phase II Study of Acute Promyelocytic Leukemia (APL)

Editorial: Arsenic--new life for an old potion

Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries through International Cooperative Network. Report On the International Consortium On Acute Promyelocytic Leukemia Study Group

Suchergebnisse filtern